Thyrocare Technologies reported FY26 consolidated revenue of ₹829.04 Crore and PAT of ₹162.85 Crore. The Board recommended a final dividend of ₹7.00 per share and approved the appointment of Price Waterhouse LLP as Statutory Auditors. The company also announced a ₹5.50 Crore investment in its wholly-owned subsidiary, Think Health Diagnostics.